{"title": "Un paso m\u00e1s cerca de conseguir una vacuna contra el c\u00e1ncer", "author": "KIM KYUNG-HOON", "url": "https://theobjective.com/sociedad/2016-06-02/probada-con-exito-una-vacuna-contra-el-cancer/", "hostname": "theobjective.com", "description": "Los investigadores han utilizado nanopart\u00edculas que contienen ARN (mol\u00e9culas que le permiten al ADN producir prote\u00ednas) de un tumor para simular la intrusi\u00f3n de un pat\u00f3geno en el circuito sangu\u00edneo para desencadenar una respuesta del sistema inmunitario. Las pruebas determinaron que cuando esas part\u00edculas entran en contacto con las c\u00e9lulas dendr\u00edticas y los macr\u00f3fagos (un tipo de gl\u00f3bulos blancos) presentes en el bazo, los n\u00f3dulos linf\u00e1ticos o la m\u00e9dula \u00f3sea activan los mecanismos de autodefensa habituales para combatir cualquier virus. El sistema ha sido usado en varios modelos de tumores en ratones y en tres enfermos de melanoma, observando que el mecanismo ten\u00eda los efectos esperados y una respuesta positiva del sistema inmune. Aunque a\u00fan es pronto para asegurar que esta estrategia ser\u00e1 eficaz contra el c\u00e1ncer, sin duda es un avance que despierta la esperanza.", "sitename": "The Objective", "date": "2016-06-02", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Un paso m\u00e1s cerca de conseguir una vacuna contra el c\u00e1ncer\nLos investigadores han utilizado nanopart\u00edculas que contienen ARN (mol\u00e9culas que le permiten al ADN producir prote\u00ednas) de un tumor para simular la intrusi\u00f3n de un pat\u00f3geno en el circuito sangu\u00edneo para desencadenar una respuesta del sistema inmunitario. Las pruebas determinaron que cuando esas part\u00edculas entran en contacto con las c\u00e9lulas dendr\u00edticas y los macr\u00f3fagos (un tipo de gl\u00f3bulos blancos) presentes en el bazo, los n\u00f3dulos linf\u00e1ticos o la m\u00e9dula \u00f3sea activan los mecanismos de autodefensa habituales para combatir cualquier virus. El sistema ha sido usado en varios modelos de tumores en ratones y en tres enfermos de melanoma, observando que el mecanismo ten\u00eda los efectos esperados y una respuesta positiva del sistema inmune. Aunque a\u00fan es pronto para asegurar que esta estrategia ser\u00e1 eficaz contra el c\u00e1ncer, sin duda es un avance que despierta la esperanza.\nUn grupo de la Universidad de Maguncia (Alemania) ha probado en ratones y en tres pacientes con un melanoma avanzado una vacuna que permite al sistema inmune responder contra algunos tumores. Se trata de un importante paso para alcanzar uno de los avances cient\u00edficos m\u00e1s ansiados: una vacuna universal contra el c\u00e1ncer.\nLos investigadores han utilizado nanopart\u00edculas que contienen ARN (mol\u00e9culas que le permiten al ADN producir prote\u00ednas) de un tumor para simular la intrusi\u00f3n de un pat\u00f3geno en el circuito sangu\u00edneo para desencadenar una respuesta del sistema inmunitario. Las pruebas determinaron que cuando esas part\u00edculas entran en contacto con las c\u00e9lulas dendr\u00edticas y los macr\u00f3fagos (un tipo de gl\u00f3bulos blancos) presentes en el bazo, los n\u00f3dulos linf\u00e1ticos o la m\u00e9dula \u00f3sea activan los mecanismos de autodefensa habituales para combatir cualquier virus. El sistema ha sido usado en varios modelos de tumores en ratones y en tres enfermos de melanoma, observando que el mecanismo ten\u00eda los efectos esperados y una respuesta positiva del sistema inmune. Aunque a\u00fan es pronto para asegurar que esta estrategia ser\u00e1 eficaz contra el c\u00e1ncer, sin duda es un avance que despierta la esperanza.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2016/06/cancer-e1464885217811.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/kim-kyung-hoon-2/", "https://theobjective.com/autor/kim-kyung-hoon-2/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer&via=TheObjective_es", "//web.whatsapp.com/send?text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&title=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer%20The Objective", "/cdn-cgi/l/email-protection#556a2620373f30362168013070676525203031307067653c3b213027302634277b7b7b73373a312c68003b7067652534263a706765387016667014642670676536302736347067653130706765363a3b263032203c27706765203b34706765233436203b34706765363a3b2127347067653039706765367016667014643b3630277067653d21212526706614706713706713213d303a373f3036213c23307b363a38706713263a363c303134317067136765646378656378656770671325273a3734313478363a3b78302d3c213a78203b3478233436203b3478363a3b2127347830397836343b363027706713", "https://theobjective.com/autor/kim-kyung-hoon-2/", "https://theobjective.com/autor/kim-kyung-hoon-2/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer&via=TheObjective_es", "//web.whatsapp.com/send?text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&title=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2016-06-02%2Fprobada-con-exito-una-vacuna-contra-el-cancer%2F&text=Un%20paso%20m%C3%A1s%20cerca%20de%20conseguir%20una%20vacuna%20contra%20el%20c%C3%A1ncer%20The Objective", "/cdn-cgi/l/email-protection#d0efa3a5b2bab5b3a4ed84b5f5e2e0a0a5b5b4b5f5e2e0b9bea4b5a2b5a3b1a2fefefef6b2bfb4a9ed85bef5e2e0a0b1a3bff5e2e0bdf593e3f591e1a3f5e2e0b3b5a2b3b1f5e2e0b4b5f5e2e0b3bfbea3b5b7a5b9a2f5e2e0a5beb1f5e2e0a6b1b3a5beb1f5e2e0b3bfbea4a2b1f5e2e0b5bcf5e2e0b3f593e3f591e1beb3b5a2f5e2e0b8a4a4a0a3f5e391f5e296f5e296a4b8b5bfb2bab5b3a4b9a6b5feb3bfbdf5e296a3bfb3b9b5b4b1b4f5e296e2e0e1e6fde0e6fde0e2f5e296a0a2bfb2b1b4b1fdb3bfbefdb5a8b9a4bffda5beb1fda6b1b3a5beb1fdb3bfbea4a2b1fdb5bcfdb3b1beb3b5a2f5e296", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/cancer/", "https://theobjective.com/etiqueta/melanoma/", "https://theobjective.com/etiqueta/sistema-inmunitario/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2016-05-06/shakira-disena-munecas-para-colaborar-con-los-ninos-con-cancer/", "https://theobjective.com/espana/2016-05-13/el-80-de-los-habitantes-de-las-ciudades-respiran-aire-contaminado/", "https://theobjective.com/sociedad/2016-05-10/sentihealth-analiza-emociones-de-pacientes-con-cancer-a-traves-de-las-redes-sociales/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}